MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $295,000 | -83.1% | 6,950 | -54.6% | 0.10% | -82.4% |
| Q2 2015 | $1,748,000 | -2.5% | 15,310 | +10.3% | 0.56% | +4.3% |
| Q1 2015 | $1,792,000 | +75.3% | 13,885 | +35.3% | 0.54% | +78.7% |
| Q4 2014 | $1,022,000 | -13.2% | 10,260 | -13.8% | 0.30% | -13.5% |
| Q3 2014 | $1,177,000 | +18.2% | 11,900 | -7.9% | 0.35% | +5.8% |
| Q2 2014 | $996,000 | +0.3% | 12,925 | -16.2% | 0.33% | -6.0% |
| Q1 2014 | $993,000 | – | 15,430 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |